Scientists hunt superbug in water and people to stop its spread

NCT ID NCT05282082

Completed Knowledge-focused Sponsor: Erasmus Medical Center Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study aimed to create a smart surveillance strategy for carbapenem-resistant Pseudomonas aeruginosa (CRPA), a superbug that causes hard-to-treat infections in hospitals. Researchers collected samples from over 2,100 healthy people, patients, and hospital environments in the Netherlands, Italy, and Indonesia. By analyzing the bacteria's DNA, they hope to identify transmission routes and develop a global plan to prevent further spread.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could lead to a globally-applicable surveillance strategy to guide actions against the spread of CRPA in hospitals and communities.
What could go wrong: This is an observational study, not a treatment trial. It provides insights but does not directly test any intervention or cure.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COLONIZATION, ASYMPTOMATIC are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Asymptomatic Infections nosocomial infection Pseudomonas aeruginosa infectious disease Pseudomonas infection

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

COLONIZATION, ASYMPTOMATIC NOSOCOMIAL INFECTION PSEUDOMONAS AERUGINOSA

Contacts and locations

Locations

Dr Cipto Mangunkusumo General Hospital

Jakarta, Indonesia
Erasmus Medical Center

Rotterdam, South Holland, 3015 GD, Netherlands
Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Roma, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.